Longitudinal changes in free-water within the substantia nigra of Parkinson's disease - Wikidata - awgldk - TriplyDB

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

http://www.wikidata.org/entity/Q30952963

about

Global, Yet Incomplete Overview of Cohort Studies in Parkinson's disease.Free-water imaging in Parkinson's disease and atypical parkinsonism.The role of biomarkers and imaging in Parkinson's disease.Free-water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO-B inhibitor.Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6.In vivo imaging reveals impaired connectivity across cortical and subcortical networks in a mouse model of DYT1 dystonia.Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects.Intracranial Fluid Redistribution But No White Matter Microstructural Changes During a Spaceflight Analog.Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease A Method for Automated Classification of Parkinson's Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI.Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Separating blood and water: Perfusion and free water elimination from diffusion MRI in the human brain.Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.The NINDS Parkinson's disease biomarkers program.Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis Lateralized basal ganglia vulnerability to pesticide exposure in asymptomatic agricultural workers.Aortic Stiffness, Increased White Matter Free Water, and Altered Microstructural Integrity: A Continuum of Injury.Magnetic resonance imaging for the diagnosis of Parkinson's disease.In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.A test-retest study on Parkinson's PPMI dataset yields statistically significant white matter fascicles.Dose-dependent white matter damage after brain radiotherapy.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.Progression marker of Parkinson's disease: a 4-year multi-site imaging study.Forebrain knock-out of torsinA reduces striatal free-water and impairs whole-brain functional connectivity in a symptomatic mouse model of DYT1 dystonia.Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.Alteration of putaminal fractional anisotropy in Parkinson's disease: a longitudinal diffusion kurtosis imaging study.The whole-brain pattern of magnetic susceptibility perturbations in Parkinson's disease.Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease.Free water determines diffusion alterations and clinical status in cerebral small vessel disease.Genetic markers of dopaminergic transmission predict performance for older males but not females.Multimodal neuroimaging and behavioral assessment of α-synuclein polymorphism rs356219 in older adults.Current Clinical Applications of Diffusion-Tensor Imaging in Neurological Disorders.Design and validation of diffusion MRI models of white matter.Can neuroimaging predict dementia in Parkinson's disease?Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques

P2860

Q30491906-D73F0F4B-4375-4126-981C-E041FF98E218 Q31034031-47B501CF-4F79-43B8-AC24-DDDBC6725306 Q31041660-950DB6A1-B2C6-487A-B86A-AF3DC1CDF1AB Q31080092-CC6CD526-9532-41BC-A6D5-7FBB0E256B15 Q31111140-50249C6B-0D25-4AC9-83D8-42B49C3BF414 Q31114074-0C207BF5-AFDE-4ADF-8719-6666B7F50949 Q31121409-6C1873AB-4D21-4CF0-B5A8-BDEE6522AE18 Q33784438-B81CD4E0-12EA-4586-BA9C-84E6BC27C270 Q33831798-C67F87E4-0B25-404B-904F-99B95815DCF2 Q35880760-242DB7CC-382B-406D-9119-013971A82188 Q36046525-0EF99A26-0317-405F-8532-6F567AE0725B Q36178546-14E5D1E9-F784-4FE1-89E9-4BF44E5A8F95 Q36301580-629127CF-0EDE-4399-8E59-EF449E4F51EC Q36332532-912A7CB5-695E-4054-9737-2D611FEFAE44 Q36347799-E95F2268-18BD-41D2-9A79-0FA4448257ED Q36395669-19EF87ED-04D9-4D2F-85D0-C886D1D75295 Q36777618-C8228EE7-76C6-43B6-ADB5-5B0067DB9DFD Q38647751-21B56DA6-3E4E-4B11-B74A-907773F5E9BE Q38668885-7889A2D9-C5E0-46AC-A800-01A5A2DA10C2 Q38687595-E7B81401-ECD2-4BC5-8C02-2958D2B3D53D Q39220904-4BE1646A-1993-4FA9-BC9D-B50569C0750B Q39758264-8F1019B6-43F8-4DEC-8AEA-A915225A2432 Q41288971-D909CE7D-8BB5-48F0-B4B7-EBF98B68DC93 Q42796545-77DA9389-C295-4D89-A469-A57B67CE77E3 Q46354756-339F7683-B8FF-4DBA-9473-8B088CF75DDC Q47119321-5116260B-33AA-4DDA-B8B5-0823585BFE85 Q47338262-9031DDB8-A6DD-468B-A934-7C3C7789628C Q47683720-8C54C977-2B9B-4AF0-96F9-0738511ECCB1 Q47837712-240742E6-2E8B-4904-B412-DD49F970BF18 Q47998172-EA12BAB2-521B-49F3-A85A-2D7C32FF278E Q48170789-0889C580-5A01-4E2E-B969-AE07E20C6EBC Q48432793-D22DD7A4-770B-4FC3-BF58-977577C92CA2 Q50054077-D9CE05F1-ADE0-45F1-BDBD-7A05280660A0 Q50185247-7E77BF56-C4C0-4DB5-A0A9-424907A21554 Q50531394-E583E0BB-9175-41B3-ABF5-A9DEB8856F2E Q51765701-84A81C93-FDBE-47C6-B591-F088F635E1CE Q52674609-AE3D693A-B80E-4596-8532-96C8C8750B11 Q53821833-F946B094-B7E7-44E3-802F-5CF320AC0CC7 Q58696822-866FCA18-2CA4-445B-BAED-13F76BDD5726 Q58763751-592F1654-C964-4433-B1E9-451BCDF5F724

P2860

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

http://www.wikidata.org/entity/Q30952963

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

@ast

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

@en

type

label

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

@ast

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

@en

prefLabel

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

@ast

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

@en

P1433

Q30952963-77761910-43F5-4C54-9761-3D8A7665DEED

P1476

Q30952963-AE1A4DB9-8006-4E7E-9EA7-24FFF768C889

P2093

Q30952963-37768734-D41F-4E00-AB66-93F8F679600B

Q30952963-4620B19B-3B44-447C-AE42-514B80E0F292

Q30952963-68809B2A-0E73-4567-809D-4E3542AB12F8

Q30952963-6E212769-6843-4C03-864A-E2B91B4B2913

Q30952963-83A0528F-9252-48B7-8920-2573A29AF13E

Q30952963-976BE272-7766-4466-8498-D8DC1F3C9216

Q30952963-FB211EE8-3E82-484E-8A4E-1740AFAAB07B

P2860

Q30952963-065C2E59-FEC7-45A6-909F-4C9077F70A75

Q30952963-0A459B77-6ABC-487E-80EC-FA88216756E1

Q30952963-13DC3097-1ABB-4769-BF22-E9BF362752F2

Q30952963-182F1F81-C079-4EBD-AF5A-3EC34D09F5CD

Q30952963-2917A80B-3CFD-43BA-AE29-A9AA3AFDA9C6

Q30952963-2D261391-159B-444C-B261-30010AF727FD

Q30952963-4997679F-EFCC-4BE8-857F-23948F1047F7

Q30952963-4A90DB1F-605E-4C05-8209-272A09810B9F

Q30952963-5264D30A-F6C3-4574-966F-4EDE57C114D2

Q30952963-57EBC855-E004-448E-B139-DF55D380EF1A

P304

Q30952963-3BB67EA0-93A5-4176-9894-6EE4ACBD730C

P31

Q30952963-F9A53197-7D5F-4972-A4F4-2BCF7537D631

P356

Q30952963-93980FAA-D155-4049-9A03-5B8544611E27

P407

Q30952963-DFE95D47-446A-4269-A59C-768CBE038732

P433

Q30952963-A65AD51A-86D8-4681-8216-869B599E32B0

P478

Q30952963-235C1550-9707-4F44-B9C1-C09D511AF467

P50

Q30952963-6C3C5BCE-E4FF-45C1-9375-38A96BDC0B5B

Q30952963-DB2E05ED-9247-4A0E-847D-47F6431C03FA

P577

Q30952963-7BCC90D3-6E61-4FA4-BC85-59F714E307AA

P5875

Q30952963-87B2AC34-3AD3-45EC-AA5E-BF60EDEEDD15

P698

Q30952963-7E1566F3-4B6E-426D-99CE-B414C05838E1

P921

Q30952963-55774B18-9795-45A1-AA72-7A6C3C3280FD

Q30952963-D49EDBB5-E2FB-4362-A6AA-B52B2F1E5B1C

P932

Q30952963-30486C00-A5C8-440D-A1D3-382C57CE4B0B

P356

P1433

P1476

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

@en

P2093

Amy F Snyder

http://www.w3.org/2001/XMLSchema#string

David E Vaillancourt

http://www.w3.org/2001/XMLSchema#string

Hong Li

http://www.w3.org/2001/XMLSchema#string

Ofer Pasternak

http://www.w3.org/2001/XMLSchema#string

Peggy J Planetta

http://www.w3.org/2001/XMLSchema#string

Roxana G Burciu

http://www.w3.org/2001/XMLSchema#string

Song Lai

http://www.w3.org/2001/XMLSchema#string

P2860

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease

An Inventory for Measuring Depression

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts

Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI

Ageing and Parkinson's disease: substantia nigra regional selectivity

Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.

Quantification of iron in the non-human primate brain with diffusion-weighted magnetic resonance imaging.

Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.

P304

2322-2331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWV136

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 8

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Okun

P577

2015-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276420904

http://www.w3.org/2001/XMLSchema#string

P698

25981960

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

substantia nigra

P932

4840947

http://www.w3.org/2001/XMLSchema#string